Exhibiting at VIV Asia 2025

Shanghai Hanvet Bio-pharm Co., Ltd. is a leading veterinary pharmaceutical manufacturer and high-tech enterprise based in Shanghai, China. With decades of experience in the development, production, and distribution of animal health products, Hanvet has built a strong reputation for providing science-driven, GMP-compliant, and globally recognized veterinary solutions.

Company Background

Founded with the mission of advancing animal health through biotechnology, Shanghai Hanvet Bio-pharm is dedicated to the research and manufacturing of high-quality veterinary drugs. The company integrates modern pharmaceutical technology with veterinary science, offering a broad range of products to support livestock and companion animal health.

Hanvet’s operations are supported by state-of-the-art production facilities, an experienced R&D team, and strategic partnerships with veterinary institutions and academic research centers.

Core Business and Product Portfolio

Hanvet's diverse product range spans multiple therapeutic areas in veterinary medicine, including:

• Antibiotics

  • Enrofloxacin Oral Solution: Broad-spectrum fluoroquinolone for poultry and livestock bacterial infections
  • Amoxicillin Soluble Powder: Penicillin-class antibiotic used in respiratory and gastrointestinal infections

• Antiparasitics

  • Ivermectin Injection: Effective treatment for internal and external parasites in cattle, sheep, pigs, and poultry

• Antifungals

  • Ketoconazole Tablets: Used for fungal infections in pets and livestock

• Nutritional Supplements

  • Multivitamin Syrup: Liquid formulation to boost immunity and recovery in animals under stress or illness

Each product is manufactured with stringent quality control under GMP-compliant protocols, ensuring safety, efficacy, and regulatory compliance for global markets.

Unique Selling Proposition (USP)

Hanvet stands out in the competitive veterinary pharmaceutical sector through:

• Vertical integration of R&D, formulation, manufacturing, and regulatory support
• A portfolio that combines modern antibiotics with essential nutritional and antiparasitic solutions
• Proven capability in oral liquids, powders, tablets, and injectables
• Experience in both companion and food-producing animal therapeutics
• Technical support for registration, labeling, and regulatory dossiers in international markets

This comprehensive approach enables Hanvet to support end-to-end pharmaceutical supply solutions for veterinary distributors and public health authorities.

Financial & Export Performance

Though specific revenue figures are undisclosed, Shanghai Hanvet Bio-pharm is an active exporter and supplier, with consistent international engagement:

• Export Regions: Asia, Middle East, Africa, and South America
• Products listed on Made-in-China, Alibaba, and through authorized international partners
• Participated in government procurement programs and tenders for livestock vaccination and treatment drives
• Long-standing supply relationships with veterinary wholesalers and importers in over 20 countries

Shipment data shows recurring orders for enrofloxacin solutions and ivermectin injectables, reflecting high product acceptance in the field.

Target Market

Hanvet serves a broad spectrum of clients across the veterinary pharmaceutical chain, including:

• Veterinary hospitals and clinics
• Livestock farms and integrators
• Animal health distributors and importers
• Public sector veterinary services
• Pet care and OTC (over-the-counter) brands through private labeling

The company offers flexibility in formulation customization, packaging sizes, and branding for diverse market needs.

Capabilities

Hanvet operates GMP-certified manufacturing facilities, with capacity to produce multiple dosage forms:

• Dedicated lines for oral solutions, soluble powders, tablets, and injections
• In-house quality control labs equipped with HPLC, UV spectrometry, and microbial testing
• R&D division that collaborates on new molecule development, formulation enhancements, and stability trials
• Regulatory affairs team capable of compiling CTD dossiers and VICH-compliant documentation

Its production and logistics systems are designed to meet the demands of high-volume export markets while ensuring compliance with destination country regulations.

Certifications and Compliance

Shanghai Hanvet Bio-pharm adheres to strict quality and regulatory standards:

• GMP Certification for Veterinary Pharmaceuticals (issued by China’s Ministry of Agriculture)
• ISO9001 Quality Management System (internal implementation)
• Compliance with WHO, OIE, and VICH guidelines for animal drug safety
• Pre-qualified product registrations in multiple export markets

These certifications allow the company to participate in global veterinary healthcare programs and institutional supply chains.

Customer Testimonials

Although specific testimonials are not widely published, client feedback indicates:

• Reliable product performance in livestock disease control
• Competitive pricing and value proposition
• High satisfaction with regulatory support and shipment documentation
• Responsive after-sales service and technical assistance from veterinary professionals on staff

Repeat business from distributors and government buyers reflects the company’s credibility and operational consistency.

Achievements and Recognition

• Designated as a High-Tech Enterprise by Shanghai municipal authorities
• Developed a proprietary formulation of Enrofloxacin Oral Solution with enhanced stability and absorption
• Participated in regional animal health campaigns targeting zoonotic disease prevention
• Recognized as a preferred partner for veterinary antibiotic procurement in several developing countries

Shanghai Hanvet Bio-pharm Co., Ltd. remains committed to global animal health by offering safe, effective, and accessible veterinary pharmaceutical solutions. Through scientific rigor, manufacturing excellence, and customer-focused services, Hanvet continues to expand its footprint as a trusted name in veterinary medicine.